Skip to Content Skip to Search
Belamaf tumor rendering

Our disease areas of focus

Our R&D approach of Science x Technology x Culture is helping to fight cancer on multiple groundbreaking fronts – immuno-oncology, cancer epigenetics, cell therapy, and synthetic lethality. Through this approach, GSK is developing solutions for some of the most challenging cancers, including multiple myeloma.

The ongoing DREAMM clinical trial program presented at ASH underscores our commitment to advancing research and improving patient outcomes for those living with blood cancer.

Patient stories

Everyone with multiple myeloma has a different experience. Hear from Chris as he describes his journey with multiple myeloma.

Multiple Myeloma Backgrounder

Learn more about multiple myeloma.